A biochemical study of tardive dyskinesia in young male patients.

No abstract is available for this paper.

• Publication year

  1981

• Venue

  Psychiatry Research

• Publication date

  1981-06-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1016/0165-1781(81)90034-2PMID 6115438
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A probable neuroleptic effect on platelet monoamine oxidase in chronic schizophrenic patients.

  1981cited by this paper
• An effect of neuroleptic medication on plasma dopamine-beta-hydroxylase activity.

  1981cited by this paper
• Increased whole blood serotonin concentrations in chronic schizophrenic patients.

  1981cited by this paper
• Sources of error in the determination of platelet monoamine oxidase: a review of methods.

  1980cited by this paper
• Factors affecting determination of platelet monoamine oxidase activity.

  1980cited by this paper
• Serum dopamine-beta-hydroxylase activity in schizophrenia.

  1980cited by this paper
• Platelet monoamine oxidase and plasma amine oxidase in psychiatric patients.

  1980cited by this paper
• In search of treatment for tardive dyskinesia: review of the literature.

  1979cited by this paper
• PLATELET MONOAMINE OXIDASE AND PLASMA DOPAMINE β-HYDROXYLASE IN TARDIVE DYSKINESIA

  1979cited by this paper
• High serum neuroleptic levels in tardive dyskinesia?

  1979cited by this paper
• Relationship of the actions of neuroleptic drugs to the pathophysiology of tardive dyskinesia.

  1979cited by this paper
• Platelet monoamine oxidase and plasma dopamine beta-hydroxylase in tardive dyskinesia.

  1979cited by this paper
• Are paranoid schizophrenics biologically different from other schizophrenics?

  1978cited by this paper
• Schizophrenia in a North Swedish geographical isolate, 1900–1977. Epidemiology, genetics and biochemistry

  1978cited by this paper
• Research diagnostic criteria: rationale and reliability.

  1978cited by this paper
• A simple and sensitive radioreceptor assay for antischizophrenic drugs in blood

  1977cited by this paper
• Serum dopamine-β-hydroxylase in psychiatric patients and normals. Effect of d-amphetamine and haloperidol

  1976cited by this paper
• Reduced platelet monoamine oxidase activity in a subgroup of schizophrenic patients.

  1976cited by this paper
• Low platelet monoamine oxidase and vulnerability to schizophrenia.

  1975cited by this paper
• Serum Dopamine-β-Hydroxylase Activity: Sibling-Sibling Correlation

  1973cited by this paper
• Photometric assay of dopamine- -hydroxylase activity in human blood.

  1972cited by this paper

• Association of regulatory variants of dopamine β-hydroxylase with cognition and tardive dyskinesia in schizophrenia subjects

  2020cites this paper
• [Tardive dyskinesia: diagnosis, assessment and treatment].

  2013cites this paper
• Serum neuroleptic concentrations and tardive dyskinesia

  2004cites this paper
• A cell membrane correlate of tardive dyskinesia in patients treated with phenothiazines

  2004cites this paper
• Tardive dyskinesia in psychosis: probing abnormal metabolism with promethazine

  1999cites this paper
• Phenylalanine kinetics are associated with tardive dyskinesia in men but not in women

  1999cites this paper
• Tardive dyskinesia: probing abnormal metabolism with promethazine.

  1999cites this paper
• Genetic polymorphisms for drug metabolism (CYP2D6) and tardive dyskinesia in schizophrenia.

  1998cites this paper
• Serum Haloperidol Levels in Older Psychotic Patients.

  1996cites this paper
• The Nithsdale schizophrenia surveys

  1994cites this paper
• Neuroleptic-induced acute extrapyramidal syndromes and tardive dyskinesia.

  1993cites this paper
• High plasma clozapine levels in tardive dyskinesia.

  1993cites this paper
• The Nithsdale Schizophrenia Surveys. IX: Akathisia, Parkinsonism, Tardive Dyskinesia and Plasma Neuroleptic Levels

  1992cites this paper
• Prospective study of neuroleptic-induced dystonia in mania and schizophrenia.

  1992cites this paper
• Tardive dyskinesia.

  1990cites this paper
• CSF neurochemical study of tardive dyskinesia.

  1989cites this paper
• Serotonin Function in Tardive Dyskinesia

  1989cites this paper
• Platelet monoamine oxidase activity and tardive dyskinesia.

  1988cites this paper
• Neuroleptics and alternative treatments. Management of behavioral symptoms and psychosis in Alzheimer's disease and related conditions.

  1988cites this paper
• Late-onset schizophrenia: an overview.

  1988cites this paper
• Psychotropic Drug Blood Levels: Measurement and Relation to Behavioral Outcome in Mentally Retarded Persons

  1988cites this paper
• Noradrenergic function in schizophrenia.

  1987cites this paper
• Tardive dyskinesia and steady-state serum levels of thiothixene.

  1987cites this paper
• Early versus late onset psychosis and tardive dyskinesia.

  1986cites this paper
• Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics.

  1986cites this paper
• Psychotropic blood levels: a guide to clinical response.

  1986cites this paper
• An update on tardive dyskinesia.

  1986cites this paper
• Clinical and epidemiologic aspects of tardive dyskinesia.

  1985cites this paper
• Tioridazin - ett atypiskt neuroleptikum?: Översikt över farmakodynamiska effekter av tioridazin och dess huvudmetaboliter

  1985cites this paper
• Changes in mental condition, hyperkinesias and biochemical parameters after withdrawal of chronic neuroleptic treatment

  1985cites this paper
• A study of state-dependent reversal of tardive dyskinesia: phenomenological probe in humans.

  1985cites this paper
• Neurochemical Aspects of Schizophrenia

  1985cites this paper
• Tardive Dyskinesia: Management and New Treatment

  1984cites this paper
• Neuroleptics and antipsychotics

  1984cites this paper
• Tardive dyskinesia and the primary psychiatric diagnosis

  1984cites this paper
• Biochemical markers in the study of clinical effects and extrapyramidal side effects of neuroleptics.

  1984cites this paper
• Tardive dyskinesia. A discontinuation study.

  1984cites this paper
• Neurochemical studies on tardive dyskinesia. II. Urinary methoxyhydroxyphenylglycol and plasma dopamine-beta-hydroxylase.

  1983cites this paper
• Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients

  1983cites this paper
• Psychiatric diagnosis and risk for tardive dyskinesia.

  1983cites this paper
• Enzyme Studies in Tardive Dyskinesia. II. Familial Aspects

  1982cites this paper
• Therapeutic strategies against tardive dyskinesia. Two decades of experience.

  1982cites this paper
• Enzyme Studies in Tardive Dyskinesia. III. Noradrenergic Hyperactivity in a Subgroup of Dyskinetic Patients

  1982cites this paper
• MONOAMINE OXIDASE AND SCHIZOPHRENIA

  1982cites this paper
• Serum concentrations of thioridazine, its major metabolites and serum neuroleptic‐like activities in schizophrenics with and without tardive dyskinesia

  1982cites this paper